Novel c(RGDyK)-based conjugates of POPAM and 5-fluorouracil for integrin-targeted cancer therapy

被引：12
|
作者：
Thysiadis, Savvas [1 ]
Katsamakas, Sotirios [2 ]
Dalezis, Panagiotis [3 ]
Chatzisieri, Theodora [1 ]
Trafalis, Dimitrios [3 ]
Sarli, Vasiliki [1 ]
机构：
[1] Aristotle Univ Thessaloniki, Dept Chem, Univ Campus, Thessaloniki 54124, Greece
[2] Aristotle Univ Thessaloniki, Sch Pharm, Dept Pharmaceut Chem, Univ Campus, Thessaloniki 54124, Greece
[3] Univ Athens, Med Sch, Lab Pharmacol, 75 Mikras Asias St, Athens 11527, Greece
来源：
FUTURE MEDICINAL CHEMISTRY | 2017年 / 9卷 / 18期
关键词：
5-fluorouracil; angiogenesis; integrin a(v)beta(3); POPAM; RGD conjugate; RGD peptide; targeted drug delivery; tumor therapy; ALPHA(V)BETA(3) INTEGRIN; MALIGNANT-MELANOMA; ANILINE MUSTARDS; EXPRESSION; ADHESION; DELIVERY; DESIGN; AGENTS; PH;
D O I：
10.4155/fmc-2017-0139
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Aim: Alkylating agents and antimetabolites are cytotoxic drugs commonly used in cancer treatment. These medications are often associated with serious side effects on normal tissues and organs. Methodology: To improve the pharmacological profile of the alkylating agent POPAM and the antimetabolite 5-fluorouracil, novel integrin-targeted delivery systems based on c(RGDyK) were successfully synthesized. The new conjugates were tested in vitro against different cancer cells such as PC3, SKOV3, A549, MCF7 and MBA-MB-321. Results & conclusion: The c(RGDyK) conjugates of POPAM demonstrated better inhibitory effects and selectivity compared with c(RGDyK) and POPAM. The c(RGDyK) conjugates of 5-FUA demonstrated diverse inhibitory effects compared with c(RGDyK) and 5-FUA related to the levels of integrin expression, the conjugate stability and sensitivity of cancer cells to 5-FUA. [GRAPHICS] .
引用
收藏
页码：2181 / 2196
页数：16
相关论文
共 50 条
  • [11] Synthesis and characterizations of amla-based novel hydrogel matrix for the targeted and controlled release of the anticancer 5-fluorouracil drug
    Farooq, Kibrya
    Mankotia, Priyanka
    Sharma, Kashma
    Sharma, Vishal
    Kumar, Vaneet
    Kumar, Vijay
    COLLOID AND POLYMER SCIENCE, 2025, : 867 - 883
  • [12] Streptozocin/5-fluorouracil chemotherapy of pancreatic neuroendocrine tumours in the era of targeted therapy
    Lahner, Harald
    Mathew, Annie
    Klocker, Anna Lisa
    Unger, Nicole
    Theysohn, Jens
    Rekowski, Jan
    Joeckel, Karl-Heinz
    Theurer, Sarah
    Schmid, Kurt Werner
    Herrmann, Ken
    Fuehrer, Dagmar
    ENDOCRINE, 2022, 75 (01) : 293 - 302
  • [13] Streptozocin/5-fluorouracil chemotherapy of pancreatic neuroendocrine tumours in the era of targeted therapy
    Harald Lahner
    Annie Mathew
    Anna Lisa Klocker
    Nicole Unger
    Jens Theysohn
    Jan Rekowski
    Karl-Heinz Jöckel
    Sarah Theurer
    Kurt Werner Schmid
    Ken Herrmann
    Dagmar Führer
    Endocrine, 2022, 75 : 293 - 302
  • [14] The role of 5-fluorouracil dose in the adjuvant therapy of colorectal cancer
    Zalcberg, JR
    Siderov, J
    Simes, J
    ANNALS OF ONCOLOGY, 1996, 7 (01) : 41 - 46
  • [15] Enhanced antitumor efficacy of nanostructured lipid carrier co-loaded with docetaxel and 5-fluorouracil for targeted gastric cancer therapy
    Alyami, Hanan
    Alharthi, Sitah
    Alqahtani, Ali Jaber
    Shahmabadi, Hasan Ebrahimi
    Alavi, Seyed Ebrahim
    MEDICAL ONCOLOGY, 2025, 42 (02)
  • [16] Autophagy in 5-Fluorouracil Therapy in Gastrointestinal Cancer: Trends and Challenges
    Tang Jia-Cheng
    Feng Yi-Li
    Liang Xiao
    Cai Xiu-Jun
    中华医学杂志英文版, 2016, 129 (04) : 456 - 463
  • [17] Autophagy in 5-Fluorouracil Therapy in Gastrointestinal Cancer: Trends and Challenges
    Tang, Jia-Cheng
    Feng, Yi-Li
    Liang, Xiao
    Cai, Xiu-Jun
    CHINESE MEDICAL JOURNAL, 2016, 129 (04) : 456 - 463
  • [18] A Novel Therapy for Laryngotracheal Stenosis: Treatment With Ethosomes Containing 5-Fluorouracil
    Gu, Jian
    Mao, Xiaohui
    Li, Cong
    Ao, Huafei
    Yang, Xizhi
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2015, 124 (07) : 561 - 566
  • [19] Bacterial Ghosts Carrying 5-Fluorouracil: A Novel Biological Carrier for Targeting Colorectal Cancer
    Youssof, Abdullah M. E.
    Alanazi, Fars K.
    Salem-Bekhit, Mounir M.
    Shakeel, Faiyaz
    Haq, Nazrul
    AAPS PHARMSCITECH, 2019, 20 (02)
  • [20] 5-Fluorouracil nano-delivery systems as a cutting-edge for cancer therapy
    Valencia-Lazcano, Anai A.
    Hassan, Dilawar
    Pourmadadi, Mehrab
    Shamsabadipour, Amin
    Behzadmehr, Razieh
    Rahdar, Abbas
    Medina, Dora I.
    Diez-Pascual, Ana M.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 246
12345